Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04930159 · ClinicalTrials.gov registry record · NA
Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence
A NA study of Endometrial Cancer, sponsored by University of Washington.
- Active
- Registry status
- NA
- Development phase
- 252
- Enrollment target
- 11
- Study locations
NCT04930159 is a NA study of Endometrial Cancer that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 252 participants, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (52% lower). The trial reports 11 study locations across 10 states.
The verdict
NCT04930159, a NA study of Endometrial Cancer, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
- 11
- Study locations
Study Summary
The SISTER study is a randomized trial, looking at various modalities of social support for Black patients undergoing treatment for endometrial cancer. There are three study arms: group support, 1:1 peer support, and enhanced usual care. The primary outcome is treatment completion, and the secondary outcome is social isolation.
Conditions Studied
Interventions
- BEHAVIORAL Facilitated group support
- BEHAVIORAL 1:1 Peer Support
Study Locations (11)
Maryland
- Johns Hopkins University - Baltimore
- MedStar Health Research Institute - Columbia
Alabama
- University of Alabama - Birmingham
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Florida
- University of Miami - Miami
Illinois
- The University of Chicago - Chicago
Louisiana
- Louisiana State University - New Orleans - New Orleans
New York
- Weill Cornell Medicine - New York
North Carolina
- University of North Carolina - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2030-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04930159
The ClinicalTrials.gov registry entry for NCT04930159 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (52% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 2 interventions - of which Facilitated group support is the first listed.
NCT04930159 reports 11 study locations spanning 10 distinct geographic areas - top geographies include Maryland, Alabama, Arkansas.
Frequently Asked Questions
What is clinical trial NCT04930159 about?
NCT04930159 is a clinical study titled "Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence". The SISTER study is a randomized trial, looking at various modalities of social support for Black patients undergoing treatment for endometrial cancer. There are three study arms: group support, 1:1 peer support, and enhanced usual care. The primary outcome is treatment completion, and the secondary...
What is the current status of trial NCT04930159?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 252 participants. The study started on 2021-09-01. Estimated completion is 2030-10-31.
What conditions does trial NCT04930159 study?
This clinical trial studies the following conditions: Endometrial Cancer.
What interventions are being tested in trial NCT04930159?
The interventions under investigation include: Facilitated group support (BEHAVIORAL), 1:1 Peer Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT04930159?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04930159 being conducted?
This trial has 11 study locations across Alabama, Arkansas, Florida, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
RECRUITING · NA
-
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
RECRUITING · NA
-
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.